1- (2- (isoxazol- 3- yl)- 1H- imidazol- 4- yl)butane- 1,2,3,4- tetraol
inhibits sphingosine-1-phosphate lyase; structure in first source
Also Known As:
LX 2932; LX-2932; LX2932
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Aleem, Saadat:
1 article
(12/2010)
|
| 2. | Augeri, David J:
1 article
(12/2010)
|
| 3. | Bagdanoff, Jeffrey T:
1 article
(12/2010)
|
| 4. | Bednarz, Mark:
1 article
(12/2010)
|
| 5. | Boteju, Lakmal:
1 article
(12/2010)
|
| 6. | Brooks, Barbara:
1 article
(12/2010)
|
| 7. | Brown, Philip:
1 article
(12/2010)
|
| 8. | Carlsen, Marianne:
1 article
(12/2010)
|
| 9. | Carson, Kenneth G:
1 article
(12/2010)
|
| 10. | Dong, Li:
1 article
(12/2010)
|
Related Diseases
| 1. | Rheumatoid Arthritis
12/23/2010
- " Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)."
|
|
Related Drugs and Biologics